Adverse Drug Events Conference to Review Global Regulatory Requirements
Horsham, PA (Vocus) July 30, 2008
Professionals who are involved in all aspects of pharmaceutical safety should attend the Drug Information Association’s Adverse Drug Events in Premarketing Clinical Trials and Postmarketing Pharmacovigilance (September 18-19; Philadelphia, PA).
Expert speakers will address a range of topics related to pre-marketing clinical trials and post-marketing pharmacovigilance, providing attendees with an overview of the various activities performed by safety specialists. Discussion will center around:
US and EU Regulations for Clinical Trial Safety and Post-marketing Pharmacovigilance
Clinical Trials, Observational Studies, and MedDRA®
Pre- and Post-marketing Adverse Events, Statistical Considerations, and Special Clinical Trial Topics
Management and Minimization of Medical Product Risk
“For those new to pharmaceutical safety, this conference will review regulatory requirements and initiatives, US and international, which form the basis for compliance standards,” says Program Committee Member Stephen A. Goldman, MD, FAPA, FAPM, Managing Member, Stephen A. Goldman Consulting Services, LLC.
About the Drug Information Association (DIA)
The Drug Information Association serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.
Contact:
Joe Krasowski
215-293-5812
Joe.Krasowski @ diahome.org
# # #
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Finally, an issue that I am passionate about. I have looked for information of this caliber for the last several hours. Your site is greatly appreciated.